NCT03291288 2021-05-14Effect of Pexidartinib on the Way the Body Processes CYP3A4 and CYP2C9 Substrates (Pharmacokinetics)Daiichi SankyoPhase 1 Completed32 enrolled 22 charts
NCT01218620 2014-12-23Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced Solid TumorsNational Cancer Institute (NCI)Phase 1 Completed17 enrolled